Diversity and prevalence of the C-terminal region of Plasmodium falciparum merozoite surface protein 1 in China

Acta Tropica

Volumn 116, Issue 3, 2010, Pages 200-205

  Pan, Deng ^a   Hu, Jingying ^b   Ma, Qiang ^a   Pan, Weiqing ^b,c   Li, Ming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Diversity; Haplotype; PfMSP1; Plasmodium

Indexed keywords

MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1;

DNA; MALARIA; PARASITE; PATHOGEN; PROTEIN; PROTIST; VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHILD; CHINA; CONTROLLED STUDY; DNA SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MEROZOITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEQUENCE ANALYSIS; THAILAND; UNINDEXED SEQUENCE; VIET NAM;

CHINA; CLUSTER ANALYSIS; DNA, PROTOZOAN; GENOTYPE; HAPLOTYPES; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PREVALENCE; SEQUENCE ANALYSIS, DNA;

CHINA; THAILAND; VIET NAM;

PLASMODIUM FALCIPARUM;

EID: 77957753276     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.08.004     Document Type: Article

References (44)

1. Anderson T.J., Nair S., Sudimack D., Williams J.T., Mayxay M., Newton P.N., Guthmann J.P., Smithuis F.M., Tran T.H., van den Broek I.V., White N.J., Nosten F. Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Mol. Biol. Evol. 2005, 22:2362-2374.
2. Blackman M.J., Heidrich H.G., Donachie S., McBride J.S., Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 1990, 172:379-382.
3. Brando C., Ware L.A., Freyberger H., Kathcart A., Barbosa A., Cayphas S., Demoitie M.-A., Mettens P., Heppner D.G., Lanar D.E. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A. Infect. Immun. 2007, 75:838-845.
4. Chenet S., Branch O., Escalante A., Lucas C., Bacon D. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Malar. J. 2008, 7:93.
5. Cooper J.A. Merozoite surface antigen-I of plasmodium. Parasitol. Today 1993, 9:50-54.
6. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M., Kremsner P.G., Arnot D.E., Greenwood B.M., McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 2000, 6:689-692.
7. Da Silveira L., Ribeiro W., Kirchgatter K., Wunderlich G., Matsuoka H., Tanabe K., Ferreira M. Sequence diversity and linkage disequilibrium within the merozoite surface protein-1 (Msp-1) locus of Plasmodium falciparum: a longitudinal study in Brazil. J. Eukaryot. Microbiol. 2001, 48:433-439.
8. Diggs C.L., Ballou W.R., Miller L.H. The major merozoite surface protein as a malaria vaccine target. Parasitol. Today 1993, 9:300-302.
9. Duan J., Mu J., Thera M.A., Joy D., Kosakovsky Pond S.L., Diemert D., Long C., Zhou H., Miura K., Ouattara A., Dolo A., Doumbo O., Su X.Z., Miller L. Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7857-7862.
10. Dutta S., Haynes J.D., Barbosa A., Ware L.A., Snavely J.D., Moch J.K., Thomas A.W., Lanar D.E. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect. Immun. 2005, 73:2116-2122.
11. Egan A.F., Burghaus P., Druilhe P., Holder A.A., Riley E.M. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 1999, 21:133-139.
12. Egan A.F., Chappel J.A., Burghaus P.A., Morris J.S., McBride J.S., Holder A.A., Kaslow D.C., Riley E.M. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 1995, 63:456-466.
13. Egan A.F., Morris J., Barnish G., Allen S., Greenwood B.M., Kaslow D.C., Holder A.A., Riley E.M. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 1996, 173:765-769.
14. Escalante A.A., Cornejo O.E., Rojas A., Udhayakumar V., Lal A.A. Assessing the effect of natural selection in malaria parasites. Trends Parasitol. 2004, 20:388-395.
15. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. Online 2005, 1:47-50.
16. Ferreira M.U., Ribeiro W.L., Tonon A.P., Kawamoto F., Rich S.M. Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 2003, 304:65-75.
17. Guevara Patino J.A., Holder A.A., McBride J.S., Blackman M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 1997, 186:1689-1699.
18. Heppner J.D.G., Kester K.E., Ockenhouse C.F., Tornieporth N., Ofori O., Lyon J.A., Stewart V.A., Dubois P., Lanar D.E., Krzych U., Moris P., Angov E., Cummings J.F., Leach A., Hall B.T., Dutta S., Schwenk R., Hillier C., Barbosa A., Ware L.A., Nair L., Darko C.A., Withers M.R., Ogutu B., Polhemus M.E., Fukuda M., Pichyangkul S., Gettyacamin M., Diggs C., Soisson L., Milman J., Dubois M.-C., Garcon N., Tucker K., Wittes J., Plowe C.V., Thera M.A., Duombo O.K., Pau M.G., Goudsmit J., Ballou W.R., Cohen J. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 2005, 23:2243-2250.
19. Holder A.A., Sandhu J.S., Hillman Y., Davey L.S., Nicholls S.C., Cooper H., Lockyer M.J. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Parasitology 1987, 94:199-208.
20. Holder A.A., Freeman R.R. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J. Exp. Med. 1982, 156:1528-1538.
21. Hu J., Chen Z., Gu J., Wan M., Shen Q., Kieny M.-P., He J., Li Z., Zhang Q., Reed Z.H., Zhu Y., Li W., Cao Y., Qu L., Cao Z., Wang Q., Liu H., Pan X., Huang X., Zhang D., Xue X., Pan W. Safety and immunogenicity of a malaria vaccine. Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. PLoS One 2008, 3:e1952.
22. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., Kazura J.W., Crabb B.S. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-119) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 2004, 173:666-672.
23. Kaneko O., Kimura M., Kawamoto F., Ferreira M.U., Tanabe K. Plasmodium falciparum: allelic variation in the merozoite surface protein 1 gene in wild isolates from southern Vietnam. Exp. Parasitol. 1997, 86:45-57.
24. Malkin E., Hu J., Li Z., Chen Z., Bi X., Reed Z., Dubovsky F., Liu J., Wang Q., Pan X., Chen T., Giersing B., Xu Y., Kang X., Gu J., Shen Q., Tucker K., Tierney E., Pan W., Long C., Cao Z. A Phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria. Vaccine 2008, 26:6864-6873.
25. Mehrizi A.A., Zakeri S., Salmanian A.-H., Sanati M.H., Djadid N.D. Plasmodium falciparum: sequence analysis of the gene encoding the C-terminus region of the merozoite surface protein-1, a potential malaria vaccine antigen, in Iranian clinical isolates. Exp. Parasitol. 2008, 118:378-385.
26. Miller L.H., Roberts T., Shahabuddin M., McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 1993, 59:1-14.
27. Molineaux, L., Gramiccia, G., 1980. The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. World Health Organization.
28. Pan W., Huang D., Zhang Q., Qu L., Zhang D., Zhang X., Xue X., Qian F. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. J. Immunol. 2004, 172:6167-6174.
29. Qari S.H., Shi Y.-P., Goldman I.F., Nahlen B.L., Tibayrenc M., Lal A.A. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol. 1998, 92:241-252.
30. Ogutu B.R., Apollo O.J., McKinney D., Okoth W., Siangla J., Dubovsky F., Tucker K., Waitumbi J.N., Diggs C., Wittes J., Malkin E., Leach A., Soisson L.A., Milman J.B., Otieno L., Holland C.A., Polhemus M., Remich S.A., Ockenhouse C.F., Cohen J., Ballou W.R., Martin S.K., Angov E., Stewart V.A., Lyon J.A., Heppner D.G., Withers M.R. Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 2009, 4:e4708. MSP-1 Malaria Vaccine Working Group.
31. Roussilhon C., Oeuvray C., Muller-Graf C., Tall A., Rogier C., Trape J.-F., Theisen M., Balde A., Perignon J.-L., Druilhe P. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med. 2007, 4:e320.
32. Sakihama N., Kimura M., Hirayama K., Kanda T., Na-Bangchang K., Jongwutiwes S., Conway D., Tanabe K. Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene 1999, 230:47-54.
33. Sakihama N., Ohmae H., Bakote'E B., Kawabata M., Hirayama K., Tanabe K. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am. J. Trop. Med. Hyg. 2006, 74:31-40.
34. Shi Y.P., Sayed U., Qari S.H., Roberts J.M., Udhayakumar V., Oloo A.J., Hawley W.A., Kaslow D.C., Nahlen B.L., Lal A.A. Natural immune response to the C-terminal 19-kDa domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 1996, 64:2716-2723.
35. Siddiqui W.A., Tam L.Q., Kramer K.J., Hui G.S., Case S.E., Yamaga K.M., Chang S.P., Chan E.B., Kan S.C. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:3014-3018.
36. Takala S.L., Coulibaly D., Thera M.A., Dicko A., Smith D.L., Guindo A.B., Kone A.K., Traore K., Ouattara A., Djimde A.A., Sehdev P.S., Lyke K.E., Diallo D.A., Doumbo O.K., Plowe C.V. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med. 2007, 4:e93.
37. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
38. Tanabe K., Sakihama N., Rooth I., Bjorkman A., Farnert A. High frequency of recombination-driven allelic diversity and temporal variation of Plasmodium falciparum msp1 in Tanzania. Am. J. Trop. Med. Hyg. 2007, 76:1037-1045.
39. Tang L. Progress in malaria control in China. Chin. Med. J. 2000, 115:89-92.
40. Targett G., Greenwood B. Malaria vaccines and their potential role in the elimination of malaria. Malar. J. 2008, 7:S10.
41. Terrientes Z.I., Vergara J., Kramer K., Herrera S., Chang S.P. Restricted genetic diversity of Plasmodium falciparum major merozoite surface protein 1 in isolates from Colombia. Am. J. Trop. Med. Hyg. 2005, 73:55-61.
42. Zhang G.Q., Guan Y.Y., Zheng B., Wu S., Tang L.H. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Trop. Med. Int. Health 2009, q14:1266-1271.
43. Zhou S.S., Wang Q., Fang W., Tang L.H. Malaria situation in People's Republic of China in 2007. Chin. J. Parasitol. Parasit. Dis. 2008, 26:401-403.
44. Zhu X., Zhou L., Liu Q., Gao X. Genotype and sequence analysis of merozoite surface protein 1 of Plasmodium falciparum isolates in Yunnan province. Chin. J. Parasitol. Parasit. Dis. 1999, 17:155-158.